Prescribing Data in General Practice Demonstration Project
- Conditions
- HypertensionChronic heart failureCardiovascular - Other cardiovascular diseasesCardiovascular - Hypertension
- Registration Number
- ACTRN12611000319976
- Lead Sponsor
- ational Prescribing Service Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 500
To be eligible for inclusion in the study GPs should:
- Agree to participate in the study
- Participate in activities to improve the data quality of their GP prescribing system ie small group discussions and patient audit and feedback
- Make their data available for the evaluation
Patient data will be included of they have hypertension or chronic heart failure or are taking the relevant medications
If GPs are unwilling to participate in small group discussions
If GPs are unwilling to make their data available for the evaluation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients with hypertension (HT) receiving pharmacological treatment. This will be assessed using patient records extracted automatically and anonymously from the prescribing systems in each practice.[0, 6, 12 and 18 months];Proportion of patients with Chronic Heart Failure (CHF) receiving appropriate treatment (ie using an angiotensin-converting enzyme (ACE) inhibitor or angiotensin-receptor antagonists.) This will be assessed using patient records extracted automatically and anonymously from the prescribing systems in each practice.[0, 6, 12 and 18 months];Proportion of patients with hypertension achieving target blood pressures. This will be assessed using patient records extracted automatically and anonymously from the prescribing systems in each practice.[0, 6, 12 and 18 months]
- Secondary Outcome Measures
Name Time Method